Download FREE Report Sample
Download Free sampleCell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
NK Cell Therapy Market contains market size and forecasts of NK Cell Therapy in Global, including the following market information:
Global NK Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global NK Cell Therapy market was valued at 357.9 million in 2021 and is projected to reach US$ 981.5 million by 2028, at a CAGR of 15.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NK Cell Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma and NantWorks, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the NK Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NK Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global NK Cell Therapy Market Segment Percentages, by Type, 2021 (%)
NK Cell Therapies
NK Cell Directed Antibodies
Global NK Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global NK Cell Therapy Market Segment Percentages, by Application, 2021 (%)
Cancer
Gastrointestinal Diseases
Others
Global NK Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global NK Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NK Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies NK Cell Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
